Published in J Cardiovasc Pharmacol on January 01, 1988
Pharmacokinetics of amlodipine in hypertensive patients undergoing haemodialysis. Eur J Clin Pharmacol (2003) 0.81
Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker. Clin Pharmacol Ther (1976) 3.16
The clinical pharmacology of mexiletine. Br J Clin Pharmacol (1978) 2.56
Ischemic damage and repair in the rat proximal tubule: differences among the S1, S2, and S3 segments. Kidney Int (1978) 2.33
Access to circulation by permanent arteriovenous fistula in regular dialysis treatment. Br Med J (1967) 1.98
Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate. Clin Pharmacol Ther (1974) 1.81
Transcriptional repression by the insulator protein CTCF involves histone deacetylases. Nucleic Acids Res (2000) 1.74
Observations on the efficacy and pharmacokinetics of sotalol after oral administration. Eur J Clin Pharmacol (1976) 1.71
Mexiletine (Kö 1173) in the management of ventricular dysrhythmias. Lancet (1973) 1.68
Clinical pharmacokinetics of oral anticoagulants. Clin Pharmacokinet (1979) 1.66
Plasma digoxin concentrations in patients on admission to hospital. Br Heart J (1974) 1.46
Tubular leakage and obstruction after renal ischemia: structural-functional correlations. Kidney Int (1978) 1.45
Angiosarcoma at the site of a ligated arteriovenous fistula in a renal transplant recipient. Nephrol Dial Transplant (1993) 1.41
Pharmacokinetics of enalapril in normal subjects and patients with renal impairment. Br J Clin Pharmacol (1986) 1.38
Spectrophotofluorometric and gas-liquid chromatographic methods for the estimation of mexiletine (Kö 1173) in plasma and urine. J Pharm Pharmacol (1973) 1.36
Duration of action of beta-blocking drugs. Br Med J (1973) 1.33
Measurement of theophylline in plasma by high performance liquid chromatography. Br J Clin Pharmacol (1976) 1.31
Measurement of plasma mexiletine concentrations. Postgrad Med J (1977) 1.28
Theophylline kinetics in relation to age: the importance of smoking. Br J Clin Pharmacol (1980) 1.23
Paraquat poisoning; a review of nineteen cases. J Ir Med Assoc (1971) 1.17
Kinetics and metabolism of clobazam in animals and man. Br J Clin Pharmacol (1979) 1.16
The importance of SH-groups for enzymic activity. 7. The amino acid sequence around the essential SH-group of pig heart lactate dehydrogenase, isoenzyme I. Eur J Biochem (1967) 1.16
Potassium-sparing agents during diuretic therapy in hypertension. Br Med J (1971) 1.13
Correlation of reduction of exercise heart rate with blood levels of atenolol after oral and intravenous administration. Postgrad Med J (1977) 1.13
The development of mexiletine in the management of ventricular dysrhythmias. Postgrad Med J (1977) 1.09
Do patients take digoxin? Br Heart J (1978) 1.06
Parathormone-induced renal bicarbonate wastage in intestinal malabsorption and in chronic renal failure. Ir J Med Sci (1970) 1.04
Ecological constraints on mental health services. Am Psychol (1966) 1.00
Correction of renal bicarbonate wastage by parathyroidectomy. Implications in acid-base homeostasis. Q J Med (1971) 1.00
Survey of medication documentation at hospital discharge: implications for patient safety and continuity of care. Ir J Med Sci (2008) 0.99
Beta-adrenoceptor adaptation to acute exercise. J Physiol (1983) 0.98
Clinical and pharmacokinetic properties of a transdermal nicotine patch. Clin Pharmacol Ther (1990) 0.98
Mexiletine in normal volunteers. Br J Clin Pharmacol (1978) 0.97
The excretion of enalapril and enalaprilat in human breast milk. Eur J Clin Pharmacol (1990) 0.97
Aluminium encephalopathy: clinical and immunological features. Q J Med (1988) 0.96
Pharmacokinetics of low-dose methotrexate in children receiving maintenance therapy for acute lymphoblastic leukaemia. Cancer Chemother Pharmacol (1982) 0.94
Paraquat poisoning in agricultural workers. Ir Med J (1978) 0.94
Effects of thyroid dysfunction on propranolol kinetics. Clin Pharmacol Ther (1980) 0.92
Qualities for the community psychologist. Am Psychol (1971) 0.92
The changing pattern of paraquat poisoning: an epidemiologic study. Ir Med J (1978) 0.91
Acute severe intravascular haemolysis: an unrecognised cause of pancreatitis. Br Med J (Clin Res Ed) (1981) 0.91
Delta infection without increase in severity of hepatitis. Lancet (1982) 0.90
Lymphocyte cyclic AMP production in the elderly: the effects of prostaglandin E1. Br J Clin Pharmacol (1981) 0.90
Glomerulonephritis after ventriculo-atrial shunt. QJM (1995) 0.89
Monolobar Caroli's disease. Am J Gastroenterol (1989) 0.88
Radioreceptor assay for labetalol. Br J Clin Pharmacol (1981) 0.87
Cardiac sensitivity to isoprenaline, lymphocyte beta-adrenoceptors and age. Clin Sci (Lond) (1984) 0.87
Human lymphocyte beta-adrenoceptor density in relation to age and hypertension. J Cardiovasc Pharmacol (1982) 0.86
Patient-controlled analgesia using a miniature electrochemically driven infusion pump. Br J Anaesth (1994) 0.86
Relationship of beta-adrenoreceptor density to fitness in athletes. Nature (1982) 0.86
Gastric versus duodenal feeding in patients with neurological disease: a pilot study. J Neurosci Nurs (2001) 0.85
Plasma protein binding of propranolol and isoprenaline in hyperthyroidism and hypothyroidism. Br J Clin Pharmacol (1978) 0.85
Recurrent glomerulonephritis in renal transplants: fourteen years' experience. Nephrol Dial Transplant (1989) 0.85
Lower prevalence of anti-hepatitis C antibody in dialysis and renal transplant patients in Ireland. Ir J Med Sci (1993) 0.85
Effect of volume expansion on hemodynamics of the hypoperfused rat kidney. J Clin Invest (1979) 0.85
Clinical and histopathologic findings in adults with the nephrotic syndrome. Ir J Med Sci (1990) 0.84
Lisinopril in hypertension associated with renal impairment. J Cardiovasc Pharmacol (1987) 0.84
The management of hydrothorax in continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int (1990) 0.83
Simultaneous presentation of IgA nephropathy and sarcoidosis. Sarcoidosis (1987) 0.83
Dysfunctional intracellular calcium homoeostasis: a central cause of neurodegeneration in Alzheimer's disease. Biochem Soc Symp (2001) 0.83
Pharmacokinetics of a microcrystalline theophylline preparation in patients with chronic obstructive airways disease. Eur J Clin Pharmacol (1978) 0.83
Pharmacokinetics of digoxin in the elderly [proceedings]. Br J Clin Pharmacol (1978) 0.82
Hepatitis E virus antibody prevalence. Lancet (1994) 0.82
Adrenergic receptors in depression. Effects of electroconvulsive therapy. Br J Psychiatry (1985) 0.82
Metabolic and cardiovascular effects of isoprenaline and salbutamol in the dog. Br J Pharmacol (1975) 0.82
Studies of the effect of thyroid dysfunction on the elimination of beta-adrenoreceptor blocking drugs. Br J Clin Pharmacol (1977) 0.82
Pharmacokinetics of ticarcillin and clavulanic acid (timentin) in relation to renal function. Antimicrob Agents Chemother (1986) 0.81
Allele-specific hybridization of lipoprotein lipase and factor-V Leiden missense mutations with direct label alkaline phosphatase-conjugated oligonucleotide probes. Genet Anal (1996) 0.81
Pharmacokinetics and metabolism of HOE 077. Preclinical studies. J Hepatol (1991) 0.81
Non-A non-B hepatitis in parenteral drug abusers. Ir Med J (1983) 0.81
Expression of pleiotrophin and its receptors in human placenta suggests roles in trophoblast life cycle and angiogenesis. Placenta (2009) 0.81
Pharmacokinetics of digoxin alone and in the presence of indomethacin therapy. Br J Clin Pharmacol (1984) 0.81
Effect of hydrochlorothiazide on the pharmacokinetics of enalapril in hypertensive patients with varying renal function. J Cardiovasc Pharmacol (1996) 0.81
Application of Crotalus atrox venom alpha-protease for amino acid sequence determination. Anal Biochem (1967) 0.81
Carcinoma of the oesophagus associated with membrano-proliferative glomerulonephritis. Postgrad Med J (1981) 0.80
Kinetics and metabolism of pyrazolones (propyphenazone, aminopyrine and dipyrone). Br J Clin Pharmacol (1980) 0.80
Parathyroid acidosis in uraemia. Q J Med (1972) 0.80
Osteomalacia in ureterosigmoidostomy. Ir J Med Sci (1969) 0.80
Sensitization to human leukocyte antigen before and after the introduction of erythropoietin. Nephrol Dial Transplant (1998) 0.80
Rapid and accurate reversed-phase high-performance liquid chromatographic determination of conjugated bile acids in human bile for routine clinical applications. Therapeutic control during gallstone dissolution therapy. J Chromatogr (1985) 0.80
Ureaplasma urealyticum chronic osteomyelitis in a patient with hypogammaglobulinemia. J Allergy Clin Immunol (1991) 0.80
Adrenoceptors mediating metabolic responses in the greyhound. Br J Pharmacol (1971) 0.80
Pharmacokinetics of lisinopril, enalapril and enalaprilat in renal failure: effects of haemodialysis. Br J Clin Pharmacol (1988) 0.80
The prevalence and significance of gastritis in patients with lower intestinal irritable bowel (irritable colon) syndrome. J Clin Gastroenterol (1982) 0.80
Lisinopril population pharmacokinetics in elderly and renal disease patients with hypertension. Br J Clin Pharmacol (1989) 0.80
Effects of ranitidine on the disposition of metoprolol. Br J Clin Pharmacol (1985) 0.80
The periodic Schiff-methenamine (PASM) staining of renal biopsies--a light electron microscopic study. Ir J Med Sci (1976) 0.80
Effects of electrical stimulation of the Gasserian ganglion on regional cerebral blood flow after induced subarachnoid hemorrhage in pigs evaluated by 99mTc-HMPAO-SPECT. Minim Invasive Neurosurg (2001) 0.80
Pharmacokinetics of amlodipine in renal impairment. Eur J Clin Pharmacol (1989) 0.80
Augmentative treatment of chronic deafferentation pain syndromes after peripheral nerve lesions. Minim Invasive Neurosurg (2000) 0.79
The clinical pharmacology of tolmesoxide. A new vasodilator antihypertensive agent. Eur J Clin Pharmacol (1982) 0.79
Extragenital choriocarcinoma in a female presenting as a gastric tumour. Br J Surg (1970) 0.79
Naturalistic observations and theory confirmation: an example. Hum Dev (1967) 0.79